Best anti aging:Helix Biomedix Inroduces New Peptide Based Skin Care Line by Lorne Caplan
Article Summary:
Article Content:
Peptides, enzymes, exfoliation and other ingredients, actives or methods of making your skin look younger, are being touted as anti-aging beauty miracles everyday. The truth is very different about what actually works and doesn’t in skin care products. That’s why most cosmetic products skirt the FDA and don’t get into the skin, which is a barrier in any case. The great majority of skin care (anti-wrinkle, refining, plumping, etc…) are simply humectants and surfactants locking in the skin or drawing moisture to the skin for the appearance of healthier skin.
In the case of Helix Biomedix, I happened to work with them over six years ago and have met with their chief science officer a number of times, doing studies with dermatologists that I employed. I am familiar with their massive peptide library which they have selectively licensed to companies like NuSkin and other big consumer products companies. I know, personally, that some of their peptides have substantial activity levels for spurring on the production of collagen and other skin supporting elements. The key in any formulation is that they must be in enough quantity and in the right delivery vehicle to work. I don’t know which peptide they are using, but I’m happy to hear that they are pushing forward their own development, although they likely know little about actually packaging and marketing a skin care line.
Similar to when Skin Medica bought the rights to Advanced Tissue Sciences technology, creating a line and growing it slowly before being buying it out. I’m sure that is what Helix is up to. They are an over the counter public company too, so they are likely trying anything, right or wrong, to boost their stock. That may be a shame as the science in the company is exceptional and they may be ignored because they are trying to “do it themselves”. After all, it takes many years and money to sell an active pharmaceutical ingredient (API) to the leading consumer products companies like P&G, J&J, L’Oreal, Revlon, etc… and that has taken it’s toll on numerous companies. Not to mention the habit of these behemoths to, shall we say, come into ownership of the technology/ingredients they might be evaluating, through other means, circumventing their erstwhile raw material suppliers.
The key here is that the management is honest, hard (very hard) working and they are truly committed and devoted to their technology and work. No, they haven’t done any double blind placebo controlled studies that are commensurate with biotech designed and accepted protocols, but frankly, neither has L’Oreal, Estee Lauder or others in the industry. Those that have would include Allergan which is a lone standout flying on the success of Botox, which has allowed them to buy up technology and companies, now being fingered as a buyout themselves.